Cargando…

Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors

Ileal neuroendocrine tumors (NETs) represent the most common neoplasm of the small intestine. Although up to 50% of patients with ileal NETs are diagnosed with multifocal disease, the mechanisms by which multifocal ileal NETs arise are not yet understood. In this study, we analyzed genome‐wide seque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhouwei, Mäkinen, Netta, Kasai, Yosuke, Kim, Grace E., Diosdado, Begoña, Nakakura, Eric, Meyerson, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384092/ https://www.ncbi.nlm.nih.gov/pubmed/32291827 http://dx.doi.org/10.1002/gcc.22850

Ejemplares similares

Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors
por: Mäkinen, Netta, et al.
Publicado: (2022)

Awareness of a mesenteric mass as a common manifestation of ileal neuroendocrine tumor
por: Kasai, Yosuke, et al.
Publicado: (2020)

Chromosome 18 Loss of Heterozygosity in Small Intestinal Neuroendocrine Tumours: Multi-Omic and Tumour Composition Analyses
por: Waterfield, Scott, et al.
Publicado: (2023)

Neuroendocrine Carcinoma of the Kidney and Bladder with Loss of Heterozygosity and Changes in Chromosome 3 Copy Number
por: Okada, Atsushi, et al.
Publicado: (2015)

Analysis of Loss of Heterozygosity in Korean Patients with Keratoacanthoma
por: Ha, Tae-Won, et al.
Publicado: (2005)

Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.
por: Brewster, S. F., et al.
Publicado: (1994)

Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas.
por: Ding, S. F., et al.
Publicado: (1992)

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
por: Grundy, R. G., et al.
Publicado: (1998)

Genomic insights into the mechanisms of FGFR1 dependency in squamous cell lung cancer
por: Mäkinen, Netta, et al.
Publicado: (2023)

Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers
por: Jernvall, P, et al.
Publicado: (1999)

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
por: Lawrence, Ben, et al.
Publicado: (2018)

Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours.
por: Gustafson, C. E., et al.
Publicado: (1994)

Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
por: Foulkes, W. D., et al.
Publicado: (1993)

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder
por: Edwards, J, et al.
Publicado: (2001)

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.
por: Foulkes, W. D., et al.
Publicado: (1993)

Frequent Loss of Heterozygosity on Chromosomes 16 and 4 in Human Hepatocellular Carcinoma
por: Zhang, Wandong, et al.
Publicado: (1990)

Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors
por: Lourenço, Nelson, et al.
Publicado: (2014)

Candidate target genes for loss of heterozygosity on human chromosome 17q21
por: DeMarchis, L, et al.
Publicado: (2004)

Candidate target genes for loss of heterozygosity on human chromosome 17q21
por: DeMarchis, L, et al.
Publicado: (2004)

Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.
por: Ding, S. F., et al.
Publicado: (1991)

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.
por: Chappell, S. A., et al.
Publicado: (1997)

Genetic Drivers of Ileal Neuroendocrine Tumors
por: Carpizo, Darren R., et al.
Publicado: (2021)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival
por: Ragnarsson, G, et al.
Publicado: (1999)

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer
por: Oesterreich, S, et al.
Publicado: (2001)

Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
por: Gudmundsson, J., et al.
Publicado: (1995)

Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.
por: Marsh, K. L., et al.
Publicado: (1998)

Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
por: Kersemaekers, A. M., et al.
Publicado: (1998)

Loss of Heterozygosity on Chromosome 1p in Thyroid Adenoma and Medullary Carcinoma, but not in Papillary Carcinoma
por: Kubo, Katsuyuki, et al.
Publicado: (1991)

Genomic Evolution in a Patient With Lung Adenocarcinoma With a Germline EGFR T790M Mutation
por: Mäkinen, Netta, et al.
Publicado: (2021)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Genetic instability in lung cancer: concurrent analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosity
por: Ninomiya, H, et al.
Publicado: (2006)

Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas.
por: Sheng, Z. M., et al.
Publicado: (1996)

Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches
por: Cleton-Jansen, A-M, et al.
Publicado: (2000)

p53 Gene Mutation and Loss of Heterozygosity of Chromosome 11 in Methylcholanthrene‐induced Mouse Sarcomas
por: Shimokado, Kiyoshi, et al.
Publicado: (1998)

Loss of Heterozygosity and Its Importance in Evolution
por: Smukowski Heil, Caiti
Publicado: (2023)

HuH-7 reference genome profile: complex karyotype composed of massive loss of heterozygosity
por: Kasai, Fumio, et al.
Publicado: (2018)

Loss of copy of MIR1-2 increases CDK4 expression in ileal neuroendocrine tumors
por: Contractor, Tanupriya, et al.
Publicado: (2020)

Sister Chromosome Pairing Maintains Heterozygosity in Parthenogenetic Lizards
por: Lutes, Aracely A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0ebs80p12icen1lq797m5tnvqe